全球兽医肿瘤市场规模、份额、趋势和成长分析报告（2026-2034）

预计兽医肿瘤市场将从 2025 年的 8.4 亿美元成长到 2034 年的 23.8 亿美元，2026 年至 2034 年的复合年增长率为 12.22%。

随着人们对宠物健康的日益关注以及动物癌症发病率的不断上升，兽医肿瘤市场正经历着强劲的成长。饲主主人越来越倾向于为他们心爱的宠物寻求先进的治疗方法，因此对兽医肿瘤服务和产品的需求也不断扩大。人们对宠物健康的日益关注，以及兽医学的进步，正在推动用于治疗动物癌症的创新治疗方法和诊断工具的研发。随着兽医诊所将肿瘤患者的专科护理置于优先地位，兽医肿瘤市场预计将进一步发展。

技术创新在塑造兽医肿瘤市场的未来前景方面发挥关键作用。磁振造影（MRI）和电脑断层扫描）等影像技术的创新提高了宠物肿瘤的检测和后续观察能力，从而实现了更早期、更准确的诊断。此外，标靶治疗和免疫疗法的发展正在革新兽医癌症治疗，为饲主提供更有效、更微创的选择。随着製造商和兽医专业人士在研发方面持续合作，预计兽医肿瘤市场将进一步采用先进的治疗方法和技术。

此外，人们对个人化医疗和宠物整体护理方法的日益关注正在影响兽医肿瘤市场。随着宠物饲主对宠物健康了解的不断深入，他们对能够充分考虑​​每位患者需求和意愿的客製化治疗方案的需求也日益增长。这一趋势正在推动整合肿瘤服务的发展，这些服务将传统疗法与治疗方法管理和疼痛管理等辅助疗法相结合。随着市场的不断发展，技术、个人化护理和整体护理方法的融合将成为兽医肿瘤领域成功的关键驱动力。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球兽医肿瘤市场（依动物类型划分）

• 市场分析、洞察与预测
• 伴侣动物（马、狗、猫）
• 家畜

5. 全球兽医肿瘤市场（依治疗方法）

• 市场分析、洞察与预测
• 化疗
• 联合治疗
• 免疫疗法
• 标靶治疗

6. 全球兽医肿瘤市场依给药途径划分

• 市场分析、洞察与预测
• 口服
• 静脉注射

7. 全球兽医肿瘤市场（按应用划分）

• 市场分析、洞察与预测
• 犬淋巴瘤
• 骨癌（OSA）
• 肥大细胞瘤
• 黑色素瘤
• 其他的

8. 全球兽医肿瘤市场（依通路划分）

• 市场分析、洞察与预测
• 医院药房
• 政府机构
• 零售药房

9. 全球兽医肿瘤市场（按地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第十章 竞争格局

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第十一章 公司简介

• 主要公司的市占率分析
• 公司简介
  • Zoetis Inc
  • Elanco
  • Boehringer Ingelheim International GmbH
  • Merck Animal Health
  • Varian Medical Systems
  • Accuray Incorporated
  • PetCure Oncology
  • AB Science
  • Karyopharm Therapeutics Inc
  • Regeneus Ltd
  • Morphogenesis Inc
  • VetDC
  • Zenoaq
  • Rhizen Pharmaceutical SA
  • AdvaVet Inc

The Veterinary Oncology Market size is expected to reach USD 2.38 Billion in 2034 from USD 0.84 Billion (2025) growing at a CAGR of 12.22% during 2026-2034.

The Veterinary Oncology Market is experiencing robust growth as the awareness of pet health and the prevalence of cancer in animals continue to rise. As pet owners increasingly seek advanced treatment options for their beloved companions, the demand for veterinary oncology services and products is expanding. The growing focus on pet wellness, coupled with advancements in veterinary medicine, is driving the development of innovative therapies and diagnostic tools for cancer treatment in animals. As veterinary practices prioritize specialized care for oncology patients, the market for veterinary oncology is expected to flourish.

Technological advancements are playing a crucial role in shaping the future of the veterinary oncology market. Innovations in diagnostic imaging, such as MRI and CT scans, are enhancing the ability to detect and monitor tumors in pets, leading to earlier and more accurate diagnoses. Additionally, the development of targeted therapies and immunotherapies is revolutionizing cancer treatment in veterinary medicine, offering more effective and less invasive options for pet owners. As manufacturers and veterinary professionals continue to collaborate on research and development, the veterinary oncology market is likely to see increased adoption of advanced treatment modalities and technologies.

Moreover, the growing emphasis on personalized medicine and holistic approaches to pet care is influencing the veterinary oncology market. As pet owners become more informed about their pets' health, there is a rising demand for tailored treatment plans that consider individual patient needs and preferences. This trend is driving the development of integrative oncology services that combine conventional treatments with complementary therapies, such as nutrition and pain management. As the market continues to evolve, the integration of technology, personalized care, and holistic approaches will be key drivers of success in the veterinary oncology sector.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Animal Type

• Companion Animal (Equine, Canine, and Feline)
• Livestock Animal

By Therapy Type

• Chemotherapy
• Combination Therapy
• Immunotherapy
• Targeted Therapy

By Mode of Administration

• Oral
• Intravenous

By Application

• Canine Lymphoma
• Osteosarcoma (OSA)
• Mast Cell Cancer
• Melanoma
• Others

By Distribution Channel

• Hospital Pharmacies
• Government Agencies
• Retail Pharmacies

COMPANIES PROFILED

• Zoetis Inc, Elanco, Boehringer Ingelheim International GmbH, Merck Animal Health, Varian Medical Systems, Accuray Incorporated, PetCure Oncology, AB Science, Karyopharm Therapeutics Inc, Regeneus Ltd, Morphogenesis Inc, VetDC, Zenoaq, Rhizen Pharmaceutical SA, AdvaVet Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL VETERINARY ONCOLOGY MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Animal Type
• 4.2. Companion Animal (Equine, Canine, and Feline) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Livestock Animal Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VETERINARY ONCOLOGY MARKET: BY THERAPY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Therapy Type
• 5.2. Chemotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Combination Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Immunotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Targeted Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VETERINARY ONCOLOGY MARKET: BY MODE OF ADMINISTRATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Mode Of Administration
• 6.2. Oral Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Intravenous Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VETERINARY ONCOLOGY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Canine Lymphoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Osteosarcoma (OSA) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Mast Cell Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Melanoma Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VETERINARY ONCOLOGY MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Distribution Channel
• 8.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Government Agencies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL VETERINARY ONCOLOGY MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Animal Type
  • 9.2.2 By Therapy Type
  • 9.2.3 By Mode Of Administration
  • 9.2.4 By Application
  • 9.2.5 By Distribution Channel
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Animal Type
  • 9.3.2 By Therapy Type
  • 9.3.3 By Mode Of Administration
  • 9.3.4 By Application
  • 9.3.5 By Distribution Channel
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Animal Type
  • 9.4.2 By Therapy Type
  • 9.4.3 By Mode Of Administration
  • 9.4.4 By Application
  • 9.4.5 By Distribution Channel
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Animal Type
  • 9.5.2 By Therapy Type
  • 9.5.3 By Mode Of Administration
  • 9.5.4 By Application
  • 9.5.5 By Distribution Channel
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Animal Type
  • 9.6.2 By Therapy Type
  • 9.6.3 By Mode Of Administration
  • 9.6.4 By Application
  • 9.6.5 By Distribution Channel
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL VETERINARY ONCOLOGY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Zoetis Inc
  • 11.2.2 Elanco
  • 11.2.3 Boehringer Ingelheim International GmbH
  • 11.2.4 Merck Animal Health
  • 11.2.5 Varian Medical Systems
  • 11.2.6 Accuray Incorporated
  • 11.2.7 PetCure Oncology
  • 11.2.8 AB Science
  • 11.2.9 Karyopharm Therapeutics Inc
  • 11.2.10 Regeneus Ltd
  • 11.2.11 Morphogenesis Inc
  • 11.2.12 VetDC
  • 11.2.13 Zenoaq
  • 11.2.14 Rhizen Pharmaceutical SA
  • 11.2.15 AdvaVet Inc